General practitioners will, in the near future, have several choices o
f how to treat patients with peptic ulcer disease, as there will be ma
ny treatment guidelines that present different combinations of acid-in
hibitory drugs, such as omeprazole, and antibiotics. However, they wil
l still be left with the problem of who to treat, because patients do
not present with a confirmed diagnosis; rather, they present with dysp
eptic symptoms.